148 related articles for article (PubMed ID: 24849765)
41. Fatigue correlates with LRRK2 G2385R variant in Chinese Parkinson's disease patients.
Fu R; Cui SS; Du JJ; He YC; Gao C; Huang P; Qian YW; Luo XG; Chen SD
Parkinsonism Relat Disord; 2017 Nov; 44():101-105. PubMed ID: 28941828
[TBL] [Abstract][Full Text] [Related]
42. Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study.
Tan EK; Peng R; Teo YY; Tan LC; Angeles D; Ho P; Chen ML; Lin CH; Mao XY; Chang XL; Prakash KM; Liu JJ; Au WL; Le WD; Jankovic J; Burgunder JM; Zhao Y; Wu RM
Hum Mutat; 2010 May; 31(5):561-8. PubMed ID: 20186690
[TBL] [Abstract][Full Text] [Related]
43. Clinical features of LRRK2 parkinsonism.
Haugarvoll K; Wszolek ZK
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S205-8. PubMed ID: 20082991
[TBL] [Abstract][Full Text] [Related]
44. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
[TBL] [Abstract][Full Text] [Related]
45. Common variation in the LRRK2 gene is a risk factor for Parkinson's disease.
Mata IF; Checkoway H; Hutter CM; Samii A; Roberts JW; Kim HM; Agarwal P; Alvarez V; Ribacoba R; Pastor P; Lorenzo-Betancor O; Infante J; Sierra M; Gómez-Garre P; Mir P; Ritz B; Rhodes SL; Colcher A; Van Deerlin V; Chung KA; Quinn JF; Yearout D; Martinez E; Farin FM; Wan JY; Edwards KL; Zabetian CP
Mov Disord; 2012 Dec; 27(14):1822-5. PubMed ID: 23115130
[TBL] [Abstract][Full Text] [Related]
46. Lrrk2 S1647T and BDNF V66M interact with environmental factors to increase risk of Parkinson's disease.
Lin CH; Wu RM; Tai CH; Chen ML; Hu FC
Parkinsonism Relat Disord; 2011 Feb; 17(2):84-8. PubMed ID: 21167764
[TBL] [Abstract][Full Text] [Related]
47. Lack of association between the LRRK2 A419V variant and Asian Parkinson's disease.
Gopalai AA; Lim SY; Aziz ZA; Lim SK; Tan LP; Chong YB; Tan CT; Puvanarajah S; Viswanathan S; Kuppusamy R; Tan AH; Lim TT; Eow GB; Norlinah MI; Li HH; Zhao Y; Ahmad-Annuar A
Ann Acad Med Singap; 2013 May; 42(5):237-40. PubMed ID: 23771111
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of pre-diagnostic symptoms did not differ between LRRK2-related, GBA-related and idiopathic patients with Parkinson's disease.
Liu SY; Zheng Z; Gu ZQ; Wang CD; Tang BS; Xu YM; Ma JH; Zhou YT; Feng T; Chen SD; Chan P;
Parkinsonism Relat Disord; 2018 Dec; 57():72-76. PubMed ID: 30119933
[TBL] [Abstract][Full Text] [Related]
49. LRRK2 variant associated with Alzheimer's disease.
Zhao Y; Ho P; Yih Y; Chen C; Lee WL; Tan EK
Neurobiol Aging; 2011 Nov; 32(11):1990-3. PubMed ID: 20018409
[TBL] [Abstract][Full Text] [Related]
50. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
[TBL] [Abstract][Full Text] [Related]
51. LRRK2 mutation in familial Parkinson's disease in a Taiwanese population: clinical, PET, and functional studies.
Lin CH; Tzen KY; Yu CY; Tai CH; Farrer MJ; Wu RM
J Biomed Sci; 2008 Sep; 15(5):661-7. PubMed ID: 18523869
[TBL] [Abstract][Full Text] [Related]
52. Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with Parkinson's disease.
Hong JH; Kim YK; Park JS; Lee JE; Oh MS; Chung EJ; Kim JY; Sung YH; Lyoo CH; Lee JH; Kwon DY; Kim HS; Shin HW; Park SA; Park IS; Kim JS; Lee PH; Koh SB; Baik JS; Kim SJ; Ma HI; Kim JW; Kim YJ
J Clin Neurosci; 2017 Feb; 36():108-113. PubMed ID: 27839916
[TBL] [Abstract][Full Text] [Related]
53. Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation.
Yahalom G; Kaplan N; Vituri A; Cohen OS; Inzelberg R; Kozlova E; Korczyn AD; Rosset S; Friedman E; Hassin-Baer S
Parkinsonism Relat Disord; 2012 Nov; 18(9):1039-41. PubMed ID: 22703868
[TBL] [Abstract][Full Text] [Related]
54. A novel LRRK2 mutation in an Austrian cohort of patients with Parkinson's disease.
Haubenberger D; Bonelli S; Hotzy C; Leitner P; Lichtner P; Samal D; Katzenschlager R; Djamshidian A; Brücke T; Steffelbauer M; Bancher C; Grossmann J; Ransmayr G; Strom TM; Meitinger T; Gasser T; Auff E; Zimprich A
Mov Disord; 2007 Aug; 22(11):1640-3. PubMed ID: 17523199
[TBL] [Abstract][Full Text] [Related]
55. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
[TBL] [Abstract][Full Text] [Related]
56. LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.
Hulihan MM; Ishihara-Paul L; Kachergus J; Warren L; Amouri R; Elango R; Prinjha RK; Upmanyu R; Kefi M; Zouari M; Sassi SB; Yahmed SB; El Euch-Fayeche G; Matthews PM; Middleton LT; Gibson RA; Hentati F; Farrer MJ
Lancet Neurol; 2008 Jul; 7(7):591-4. PubMed ID: 18539535
[TBL] [Abstract][Full Text] [Related]
57. Genomewide linkage study of modifiers of LRRK2-related Parkinson's disease.
Latourelle JC; Hendricks AE; Pankratz N; Wilk JB; Halter C; Nichols WC; Gusella JF; Destefano AL; Myers RH; Foroud T;
Mov Disord; 2011 Sep; 26(11):2039-44. PubMed ID: 21661047
[TBL] [Abstract][Full Text] [Related]
58. Heterogeneity among patients with Parkinson's disease: cluster analysis and genetic association.
Ma LY; Chan P; Gu ZQ; Li FF; Feng T
J Neurol Sci; 2015 Apr; 351(1-2):41-45. PubMed ID: 25732803
[TBL] [Abstract][Full Text] [Related]
59. Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions.
Chung SJ; Armasu SM; Anderson KJ; Biernacka JM; Lesnick TG; Rider DN; Cunningham JM; Ahlskog JE; Frigerio R; Maraganore DM
Parkinsonism Relat Disord; 2013 Jun; 19(6):595-9. PubMed ID: 23507417
[TBL] [Abstract][Full Text] [Related]
60. High Resolution Melting (HRM) for High-Throughput Genotyping-Limitations and Caveats in Practical Case Studies.
Słomka M; Sobalska-Kwapis M; Wachulec M; Bartosz G; Strapagiel D
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
